ROMOSOZUMAB AS A TREATMENT FOR OSTEOPOROSIS: PREDICTORS OF EFFICACY AT 12 MONTHS

被引：0
|
作者：
Hirano, Y. [1 ]
Ono, Y. [1 ]
机构：
[1] Toyohashi Municipal Hosp, Toyohashi, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2194
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1016
引用
收藏
页码：1631 / 1631
页数：1
相关论文
共 50 条
  • [1] Romosozumab as a Treatment for Osteoporosis: Predictors of Efficacy at 12 Months
    Hirano, Yuji
    Ohno, Yusuke
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 272 - 273
  • [2] Romosozumab as Treatment for Osteoporosis: Predictors of Efficacy at Six Months
    Hirano, Yuji
    Hasegawa, Jyunya
    Kosugiyama, Hironobu
    Kihira, Daisuke
    Hattori, Kyosuke
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 148 - 149
  • [3] Clinical efficacy of romosozumab in patients with rheumatoid arthritis and primary osteoporosis for 12 months
    Kanayama, Yasuhide
    Tsuji, Taichi
    Futamura, Naohisa
    Ota, Kyotaro
    Adachi, Yui
    Watanabe, Taku
    Terasawa, Kei
    Maeda, Kento
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 149 - 149
  • [4] CLINICAL EFFICACY OF ROMOSOZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS FOR 12 MONTHS
    Kanayama, Y.
    Sugimoto, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 59 - 60
  • [5] Romosozumab for the treatment of osteoporosis
    Bandeira, Leonardo
    Lewiecki, E. Michael
    Bilezikian, John P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (02) : 255 - 263
  • [6] Romosozumab in the treatment of osteoporosis
    Kobza, Alexandra O.
    Papaioannou, Alexandra
    Lau, Arthur N.
    Adachi, Jonathan D.
    IMMUNOTHERAPY, 2020, 12 (13) : 965 - 981
  • [7] CLINICLAL EFFICACY OF SEQUENTIAL TREATMENT AFTER ROMOSOZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS COMPARISON WITH PRIMARY OSTEOPOROSIS FOR 24 MONTHS
    Kanayama, Y.
    Hattori, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1837 - 1838
  • [8] Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
    Lim, Sian Yik
    WOMENS HEALTH, 2022, 18
  • [9] Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
    Lim, Sian Yik
    WOMENS HEALTH, 2022, 18
  • [10] Cliniclal efficacy of sequential therapy after romosozumab in patients with primary osteoporosis for 18 months
    Kanayama, Yasuhide
    Tsuji, Taichi
    Futamura, Naohisa
    Ota, Kyotaro
    Hattori, Kyosuke
    Adachi, Yui
    Tachi, Hiroto
    Watanabe, Taku
    Maeda, Kento
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 273 - 273
12345